pharmaphorum

JULY 28, 2022

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. The two primary exporters of Active Pharmaceutical Ingredients (APIs), China and India, continue to be affected by periodic lockdowns.

Pharma 86

Pharma FDA Consulting Manufacturing 86

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society.

Pharmaceutical 86

Pharmaceutical Manufacturing Medicine Competition 86

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. At the same time, a “drug lag” persists in China for global pharmaceutical companies’ products. in the U.S.

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

JULY 3, 2023

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. This is despite these sites represented only 30 percent of FY2022 inspections.

FDA 91

FDA Food and Drug Administration Manufacturing Product sample 91

PM360

AUGUST 9, 2022

Needles cause patients pain, anxiety, pose safety risks, and for some people receiving injection therapy is a traumatic experience. The FDA 510(k) submission is expected to take place in Quarter 3 2023. Pharmaceutical manufacturers can customize the solution based on the brand’s objectives and patient population’s needs.

Prescription 105

Prescription Medical Side effects Patients 105

pharmaphorum

OCTOBER 26, 2022

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We promptly discussed this need with the FDA and the agency agreed to a proposed amendment of the protocol to accommodate, in a safe manner, the patient access to the EAP.”.

Patients 69

Patients Pharma Consulting Transportation 69

World of DTC Marketing

DECEMBER 10, 2020

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. years to win FDA approval, at a median cost of $648 million.

Insurance 181

Insurance Pharma Manufacturing Retail 181

European Pharmaceutical Review

AUGUST 9, 2022

According to researchers, a ribB -based colorimetric loop-mediated isothermal amplification (LAMP) assay could become a fast and easy-to-perform detection method for testing non-sterile pharmaceuticals for BCC. Burkholderia species are one of the primary causes of non-sterile pharmaceutical product recalls and accounted for 45.3

Food and Drug Administration 84

Food and Drug Administration Pharmaceutical products Pharmaceutical Pharmaceutical manufacturing 84

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 78

Manufacturing Marketing Pharma Distribution 78

PM360

APRIL 25, 2023

biosimilars market to date, the first of eight FDA-approved Humira (adalimumab) biosimilars launched in the United States in January after years of regulatory delays. pharmaceutical industry. In perhaps the most significant moment for the U.S. 2022 was a fascinating year for biosimilars, but may prove dull to 2023.

Marketing 97

Marketing Competition Government Manufacturing 97

Pharmaceutical Technology

MAY 11, 2008

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. The pilot scheme for this has been observed by the FDA and EU Commission.

Electronics 52

Electronics Transportation Pharmaceutical manufacturing Pharmaceutical 52